Key Takeaways GE HealthCare launched the bkActiv S Series for image-guided, non-surgical urology and pelvic procedures. GEHC's bkActiv S Series offers AI tools, TruSense tech, and single-handed controls for clinician efficiency. GEHC aims to grow recurring revenue through transducer sales, service contracts, and software upgrades.GE HealthCare Technologies Inc. (GEHC) recently expanded its bkPortfolio family of Active Imaging systems with the launch of the bkActiv S Series, a next-generation ultrasound so ...

Paysign, Inc. (PAYS) closed the last trading session at $5.09, gaining 42.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $7.35 indicates a 44.4% upside potential.The mean estimate comprises five short-term price targets with a standard deviation of $0.74. While the lowest estimate of $6.50 indicates a 27.7% increase from the current price level, the most optimistic analyst expe ...

Shares of Semtech (SMTC) have gained 2.2% over the past four weeks to close the last trading session at $40.23, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $56.33 indicates a potential upside of 40%.The average comprises 12 short-term price targets ranging from a low of $43.00 to a high of $68.00, with a standard deviation of $8.32. While the lowest estimate indicates an inc ...

C3.ai, Inc. (AI) closed the last trading session at $23.98, gaining 3.6% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $30.09 indicates a 25.5% upside potential.The mean estimate comprises 11 short-term price targets with a standard deviation of $10.18. While the lowest estimate of $18.00 indicates a 24.9% decline from the current price level, the most optimistic analyst expects ...

Shares of Rapt Therapeutics (RAPT) have gained 1.7% over the past four weeks to close the last trading session at $7.84, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $30 indicates a potential upside of 282.7%.The average comprises four short-term price targets ranging from a low of $8.00 to a high of $48.00, with a standard deviation of $21.04. While the lowest estimate indic ...

ARRAY Technologies to Acquire APA Solar DISCLAIMER Non-GAAP Financial Information This presentation includes certain financial measures that are not presented in accordance with U.S. generally accepted accounting principles ("GAAP"), including EBITDA. "EBITDA" means, with reference to any historical period of APA Solar, as net income (loss) to common shareholders plus interest expense, income tax expense (benefit), depreciation, and amortization. We believe that the presentation of EBITDA enhances the reade ...

- First use of camel hemoglobin as a universal oxygen carrier - Unique properties make it an ideal ingredient for oxygen transport BOSTON, MASSACHUSETTS, June 18, 2025 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTCQB: BIXT) (the “Company”), a clinical stage biotechnology company developing drugs to treat stroke, Alzheimer’s disease, and viruses, has a secured a GMP quality source of camel hemoglobin with help from the Heme Foundation. The Heme foundation, dedicated to solving the worlds blood shortages, is partne ...

Positive Ph2 EMBRAZE Trial Demonstrating Preservation of Lean Mass with Highly Selective Anti-Myostatin Inhibitor During Tirzepatide-Induced Weight Loss June 18, 2025 © 2025 Scholar Rock, Inc. All rights reserved. Today's Speakers David L. Hallal Chief Executive Officer Akshay Vaishnaw, M.D., Ph.D. President, Research & Development © 2025 Scholar Rock, Inc. All rights reserved. 2 Agenda | TOPIC | SPEAKER | | --- | --- | | Scholar Rock's Leading | David L. Hallal | | Anti-Myostatin Platform | Chief Executive ...

鼎龙股份：铜制程抛光硬垫产品已在某主流外资逻辑厂商测试通过并取得小批量订单 智通财经6月18日电，鼎龙股份(300054.SZ)发布投资者关系活动记录表，公司CMP抛光垫产品深度渗透 国内主流晶圆厂客户，除此以外，在积极进行外资晶圆厂商市场的推广，铜制程抛光硬垫产品已在某主 流外资逻辑厂商测试通过并取得小批量订单。公司已布局20余款高端晶圆光刻胶，已有12款送样客户端 验证，其中7款进入加仑样阶段，整体测试进展顺利。2024年度，公司已有两款光刻胶产品分别收到共 两家国内主流晶圆厂客户的订单。 ...

美联储会议前夕，美国初请数据温和落地。 上周，美国初请失业金人数有所下降，但仍稳定在八个月来的最高水平附近。 数据公布后，金融市场反应温和，但避险情绪有所显现。 截至发稿，美股三大指数小幅上涨，纳指涨0.62%，标普500指数涨0.55%，道指涨0.62%。 | 名称 ^ | 最新价 | 涨跌额 | 涨跌幅 | | --- | --- | --- | --- | | 道琼斯指数 | 42479.04 | +263.24 | +0.62% | | :DJI | | | | | 纳斯达克综合指数 | 19642.50 | +121.40 | +0.62% | | IXIC | | | | | 标普500指数 | 6015.80 | +33.08 | +0.55% | | SPX | | | | 美元指数小幅震荡，现跌0.14%报98.681；现货黄金价也格震荡走低至3387.95美元/盎司。 初请数据下降 美国劳工部周三数据显示，截至6月14日当周，美国首次申请失业救济人数减少5000人，至24.5万人， 符合市场预期。 与此同时，四周移动平均值较前一周增加4750人，达到24.55万人，创下2023年8月以来的 ...